Evidence map›Paper›PMID 33087058›Full record

ArticleBMC microbiology2020

Assaying the effect of yeasts on growth of fungi associated with disease.

Enikő Horváth, Matthias Sipiczki, Hajnalka Csoma, Ida Miklós

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. TheMolecules (Basel, Switzerland) · 2023
    Article
  4. Effect ofFrontiers in microbiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. An Updated Global Species Diversity and Phylogeny in the GenusJournal of fungi (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Enikő HorváthDepartment of Genetics and Applied Microbiology, Faculty of Science and Technology, University of Debrecen, Debrecen, Egyetem tér 1, 4032, Hungary.
Matthias SipiczkiDepartment of Genetics and Applied Microbiology, Faculty of Science and Technology, University of Debrecen, Debrecen, Egyetem tér 1, 4032, Hungary.
Hajnalka CsomaDepartment of Genetics and Applied Microbiology, Faculty of Science and Technology, University of Debrecen, Debrecen, Egyetem tér 1, 4032, Hungary.
Ida MiklósDepartment of Genetics and Applied Microbiology, Faculty of Science and Technology, University of Debrecen, Debrecen, Egyetem tér 1, 4032, Hungary. miklos.ida@science.unideb.hu.
University of Debrecen · HU

Funding

European Union and the European Social Fund EFOP-3.6.1-16-2016-00022European Union and the European Social Fund FIK 20428-3/2018
6 · The paper itself

Abstract

backgroundPathogenic fungi often cause serious infections mainly in immunocompromised persons. The number of infections caused by the non-albicans Candida or other species has significantly increased over the last years. These infections present a major challenge in the health sector because these pathogenic fungi have strong virulence and often show resistance to the commonly used antifungal treatments. To solve the problems caused by the drug resistant pathogenic fungi, it is necessary to find new antifungal agents and their sources. The aim of this study was to give evidence that yeasts can effectively fight against strains which belong to pathogenic fungi and reveal those yeasts which are able to inhibit growth of Kodamaea ohmeri, Pichia kudriavzevii, Naganishia albida or Candida tropicalis. Furthermore, we wanted to determine the effects of certain culturing factors on the growth inhibition.

resultsOur screening revealed that although the strains belonging to pathogenic species were much more tolerant to the yeast-produced bioactive agents than the non-disease-associated yeasts, growth of Kodamaea ohmeri and Candida tropicalis could be inhibited by Metschnikowia andauensis, while Naganishia albida could be controlled by Pichia anomala or Candida tropicalis. Our data proved that the experimental circumstances could have a serious impact on the inhibitory capacity of the yeasts. Appearance of inhibition strongly depended on media, pH and temperature. Our data also shed some light on the fact that Pichia kudriavzevii must have high natural resistance to the yeast-produced agents, while other species, such as Saccharomycopsis crataegensis belonged to the easily inhibitable species.

conclusionsOur study suggests that yeast-produced bioactive agents could be potential growth inhibitory agents against the disease-associated fungi and yeasts can also contribute to alternative approaches to combat against pathogenic fungi. Our data revealed an important role of the culturing factors in inhibition and pointed to the complex nature of antagonism.

Indexed as

Antifungal AgentsCandidiasisDrug Resistance, FungalMicrobial Sensitivity TestsYeastsAntifungal AgentsAntagonismBioactive agentsDisease-associated fungiMetschnikowia sp.Natural resistanceNon-albicans Candida speciesYeast

Identifiers

PMID33087058
PMCPMC7579944
OpenAlexW3094363844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.